Articles

Androgen deprivation therapy (ADT) for the treatment of prostate cancer has adverse effects that may be difficult for men to tolerate. Read More ›

Childhood cancer therapy can be a double-edged sword: it often leads to a cure, but long after treatment ends, some cancer survivors are still suffering its side effects. Read More ›

Several treatment- and disease-specific factors are associated with near miss or safety incidents (NMSIs) among patients treated with radiotherapy. Read More ›

When interacting with older adults with cancer, using appropriate communication skills is essential to achieving the intended outcome of a conversation. Read More ›

Establishing a multidis­ciplinary oral chemotherapy clinic (MOCC) in a community hospital can reduce emergency department visits, increase patient and provider satisfaction, and lead to earlier recognition of adverse events. Read More ›

PARP inhibitors were the first class of drugs specifically developed to treat BRCA-related tumors by targeting the DNA repair pathway. Although they were developed more than a decade ago, the FDA only granted approval for their clinical use a few years ago. Read More ›

Despite remarkable advance in the treatment of cancer through the use of immunotherapy, outcomes still vary, and, for some patients, these regimens provide only a short-term answer. Read More ›

The power to fight a virtually infinite array of pathogens is one of the hallmarks of the human immune system, and random diversity is its secret weapon. Read More ›

Awareness of the adverse effects of immune checkpoint inhibitors and how to manage them was the focus of several presentations at the National Comprehensive Cancer Network (NCCN) 22nd Annual Conference. Read More ›

The results of a new study presented at the 2017 Genitourinary Cancers Symposium suggest that recent use of antibiotics may compromise the efficacy of immunotherapy. Read More ›